388 related articles for article (PubMed ID: 28194856)
21. [Hepatitis E virus infection in population of non-remunerate blood donors in Shaoxing].
Sang LY; Zhuang PF; Fu LQ; Liu Y; Ge SX; Zhang J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):29-31. PubMed ID: 17429528
[TBL] [Abstract][Full Text] [Related]
22. Course of HEV viremia and anti-HEV IgM/IgG response in asymptomatic blood donors.
Kraef C; Schlein C; Hiller J; Westhölter D; Denzer U; Horvatits T; Peine S; Lohse AW; Lütgehetmann M; Polywka S; Pischke S
J Clin Virol; 2018 Aug; 105():26-30. PubMed ID: 29860111
[TBL] [Abstract][Full Text] [Related]
23. Unchanged high prevalence of antibodies to hepatitis E virus (HEV) and HEV RNA among blood donors with an elevated alanine aminotransferase level in Japan during 1991-2006.
Fukuda S; Ishikawa M; Ochiai N; Suzuki Y; Sunaga J; Shinohara N; Nozawa K; Tsuda F; Takahashi M; Okamoto H
Arch Virol; 2007; 152(9):1623-35. PubMed ID: 17533550
[TBL] [Abstract][Full Text] [Related]
24. Clinical and virological profiling of sporadic hepatitis E virus infection in China.
Wang L; Liu L; Wei Y; Wang Q; Tian Q; Wang L; Zhuang H
J Infect; 2016 Sep; 73(3):271-9. PubMed ID: 27343562
[TBL] [Abstract][Full Text] [Related]
25. [Investigation of sub-clinical infection of hepatitis E virus in blood donors].
Gao DY; Peng G; Zhu JM; Sun L; Zheng YJ; Zhang J
Zhonghua Gan Zang Bing Za Zhi; 2004 Jan; 12(1):11-2. PubMed ID: 14761272
[TBL] [Abstract][Full Text] [Related]
26. Unexpected elevated alanine aminotransferase, aspartate aminotransferase levels and hepatitis E virus infection among persons who work with pigs in accra, Ghana.
Adjei AA; Tettey Y; Aviyase JT; Adu-Gyamfi C; Mingle JA; Nartey ET
Virol J; 2010 Nov; 7():336. PubMed ID: 21092196
[TBL] [Abstract][Full Text] [Related]
27. Molecular and serological infection marker screening in blood donors indicates high endemicity of hepatitis E virus in Poland.
Grabarczyk P; Sulkowska E; Gdowska J; Kopacz A; Liszewski G; Kubicka-Russel D; Baylis SA; Corman VM; Noceń E; Piotrowski D; Antoniewicz-Papis J; Łętowska M
Transfusion; 2018 May; 58(5):1245-1253. PubMed ID: 29492976
[TBL] [Abstract][Full Text] [Related]
28. Investigation of liver dysfunction: who should we test for hepatitis E?
Wallace SJ; Webb GW; Madden RG; Dalton HC; Palmer J; Dalton RT; Pollard A; Martin R; Panayi V; Bennett G; Bendall RP; Dalton HR
Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):215-220. PubMed ID: 27832041
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis E virus in Spanish donors and the necessity for screening.
Rivero-Juarez A; Jarilla-Fernandez M; Frias M; Madrigal-Sanchez E; López-López P; Andújar-Troncoso G; Machuca I; Camacho A; Muñoz-Valbuena P; Rivero A
J Viral Hepat; 2019 May; 26(5):603-608. PubMed ID: 30661278
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of anti-HEV IgM among blood donors in Egypt.
Ibrahim EH; Abdelwahab SF; Nady S; Hashem M; Galal G; Sobhy M; Saleh AS; Shata MT
Egypt J Immunol; 2011; 18(2):47-58. PubMed ID: 23082470
[TBL] [Abstract][Full Text] [Related]
31. Serological and molecular studies on subclinical hepatitis E virus infection using periodic serum samples obtained from healthy individuals.
Mitsui T; Tsukamoto Y; Suzuki S; Yamazaki C; Masuko K; Tsuda F; Takahashi M; Tsatsralt-Od B; Nishizawa T; Okamoto H
J Med Virol; 2005 Aug; 76(4):526-33. PubMed ID: 15977233
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis E virus infection in the Irish blood donor population.
O'Riordan J; Boland F; Williams P; Donnellan J; Hogema BM; Ijaz S; Murphy WG
Transfusion; 2016 Nov; 56(11):2868-2876. PubMed ID: 27522065
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis E virus: can it be transmitted parenterally?
Arankalle VA; Chobe LP
J Viral Hepat; 1999 Mar; 6(2):161-4. PubMed ID: 10607228
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis E virus infection in Hong Kong blood donors.
Tsoi WC; Zhu X; To AP; Holmberg J
Vox Sang; 2020 Jan; 115(1):11-17. PubMed ID: 31709559
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised.
Maylin S; Stephan R; Molina JM; Peraldi MN; Scieux C; Nicand E; Simon F; Delaugerre C
J Clin Virol; 2012 Apr; 53(4):346-9. PubMed ID: 22293627
[TBL] [Abstract][Full Text] [Related]
36. Risk of hepatitis-E virus infections among blood donors in a regional blood transfusion centre in western India.
Mishra KK; Patel K; Trivedi A; Patel P; Ghosh K; Bharadva S
Transfus Med; 2021 Jun; 31(3):193-199. PubMed ID: 33738857
[TBL] [Abstract][Full Text] [Related]
37. Low hepatitis E virus RNA prevalence in a large-scale survey of United States source plasma donors.
Roth NJ; Schäfer W; Alexander R; Elliott K; Elliott-Browne W; Knowles J; Wenzel JJ; Simon TL
Transfusion; 2017 Dec; 57(12):2958-2964. PubMed ID: 28833188
[TBL] [Abstract][Full Text] [Related]
38. Estimation of the hepatitis E assay-dependent seroprevalence among Croatian blood donors.
Miletić M; Vuk T; Hećimović A; Stojić Vidović M; Jemeršić L; Jukić I
Transfus Clin Biol; 2019 Nov; 26(4):229-233. PubMed ID: 31277986
[TBL] [Abstract][Full Text] [Related]
39. Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain.
Mateos-Lindemann ML; Diez-Aguilar M; Galdamez AL; Galán JC; Moreno A; Pérez-Gracia MT
J Med Virol; 2014 Jan; 86(1):71-4. PubMed ID: 24136591
[TBL] [Abstract][Full Text] [Related]
40. [Hepatitis E virus: Blood transfusion implications].
Gallian P; Piquet Y; Assal A; Djoudi R; Chiaroni J; Izopet J; Tiberghien P
Transfus Clin Biol; 2014 Nov; 21(4-5):173-7. PubMed ID: 25267201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
